Search

Bausch Health Cos Inc

Closed

SectorHealthcare

6.5 2.69

Overview

Share price change

24h

Current

Min

6.41

Max

6.5

Key metrics

By Trading Economics

Income

1.7B

260M

Sales

363M

2.9B

P/E

Sector Avg

13.286

57.002

EPS

1.26

Profit margin

9.116

Employees

20,300

EBITDA

1.7B

1B

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+22.89% upside

Dividends

By Acuity

Next Earnings

28 paź 2026

Market Stats

By TradingEconomics

Market Cap

702M

2.4B

Previous open

3.81

Previous close

6.5

News Sentiment

By Acuity

17%

83%

43 / 340 Ranking in Healthcare

Bausch Health Cos Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

14 sie 2026, 23:52 UTC

News

Boeing Co secures over $711 million in U.S. defense contract modifications, boosting investor sentiment. Shares are higher in after-market trading.

14 sie 2026, 23:51 UTC

News

PayPal is in advanced talks for a potential sale to Stripe and Advent, following a proposal of $60.50 per share. Shares are higher in after-market trading.

14 sie 2026, 23:51 UTC

News

Tyson Foods will close its beef facility in Joslin, Illinois, resulting in about 2,500 job losses, as shares trade lower in after-market hours.

14 sie 2026, 23:46 UTC

News

Replimune Group Inc shares are lower in after-market hours amid negative sentiment from a securities fraud lawsuit related to its RP1 application.

14 sie 2026, 23:46 UTC

News

Delek US Holdings shares rose in after-market hours following Delek Logistics Partners' $230 million public offering of common units at $50.00 each.

14 sie 2026, 23:46 UTC

News

Patterson-UTI Energy reported 98 drilling rigs operating in July. Shares rose in after-market trading, reflecting strong activity and nearing the upper end of their one-month range.

14 sie 2026, 23:46 UTC

News

Kraft Heinz Co shares are lower in after-market trading following a $100 million marketing announcement and concerns over July's U.S. retail sales drop.

14 sie 2026, 23:41 UTC

News

Elliott Investment Management increased its stake in Hewlett Packard Enterprise by 17.7%, contributing to higher after-market trading for the shares.

14 sie 2026, 23:36 UTC

News

Dynatrace shares are higher in after-hours trading following Starboard Value's SEC filing disclosing an 8.9 million share stake.

14 sie 2026, 23:31 UTC

News

Texas Pacific Land Corp shares are higher in after-market hours, with a current price of $358.89 and a market capitalization of $24.75 billion.

14 sie 2026, 23:31 UTC

News

Jana Partners disclosed a new stake in Rapid7 Inc, acquiring over 6.7 million shares. Shares advanced during after-market hours following the announcement.

14 sie 2026, 23:21 UTC

News

MongoDB Inc. showcases AI focus with new Atlas Managed MCP Server tools and Voyage AI features. Shares are little changed in after-market trading.

14 sie 2026, 23:21 UTC

News

Constellation Brands shares are trading lower after Berkshire Hathaway dissolved its stake, contributing to negative sentiment amid broader weakness in the Distillers & Vintners sector.

14 sie 2026, 23:21 UTC

News

Embecta Corp shares are lower in after-market hours amid negative sentiment from two class action lawsuits alleging securities fraud and disappointing second-quarter guidance.

14 sie 2026, 23:11 UTC

News

Lattice Semiconductor granted over 414,000 RSUs and PRSUs to new employees as part of its equity incentive plan. Shares are trading roughly flat in after-market hours.

14 sie 2026, 23:11 UTC

News

Lone Pine Capital LLC reduced its stake in McKesson Corp by 85.3% to 57,851 shares, contributing to the stock's decline in after-market trading.

14 sie 2026, 23:06 UTC

News

Berkshire Hathaway raised its stake in Delta Air Lines by 44%, now holding 57.3 million shares. Shares are trading higher in after-market hours.

14 sie 2026, 23:06 UTC

News

Mastercard proposes a plan for Brazilian payment processors to absorb R$2.5 billion in losses from Banco Master’s collapse, as shares decline in after-market trading.

14 sie 2026, 23:06 UTC

News

Viking Global Investors has cut its stake in Walt Disney by a significant amount, while ValueAct Holdings has fully exited its position. Shares are lower in after-market trading.

14 sie 2026, 23:02 UTC

News

Target shares lower in after-market trading despite Telsey Advisory Group's Outperform rating and raised price target to $170. Broader market weakness weighs on performance.

14 sie 2026, 23:01 UTC

News

ServiceNow Inc shares fell in after-market trading to about $124.03 amid broader market concerns following a drop in U.S. retail sales.

14 sie 2026, 23:01 UTC

News

Berkshire Hathaway's Form 13F filing revealed a new position in DR Horton, boosting investor interest and driving shares higher in after-hours trading.

14 sie 2026, 23:01 UTC

News

Warner Bros Discovery Inc. shares declined in after-market hours amid regulatory scrutiny over its merger with Paramount Skydance Corp, facing opposition from state attorneys general.

14 sie 2026, 23:01 UTC

News
Social Media

Genco Shipping & Trading shares lower in after-market trading following Diana Shipping's withdrawal of its acquisition offer, citing unrealistic demands from Genco's Board.

14 sie 2026, 23:01 UTC

News
Social Media

Berkshire Hathaway increased its stake in Macy's to 7.3 million shares, contributing to positive sentiment as shares advanced in after-market trading.

14 sie 2026, 23:01 UTC

News

Baker Hughes Co shares are lower in after-market hours amid rising oil and gas rig counts and concerns over a decline in U.S. retail sales.

14 sie 2026, 23:01 UTC

News

MSCI Inc. shares are higher in after-market trading, reflecting a cumulative gain since Friday's close and a market capitalization of $41.38 billion.

14 sie 2026, 23:01 UTC

News

Berkshire Hathaway increased its stake in New York Times Co. by 3.7%, contributing to a modest rise in after-market trading.

14 sie 2026, 23:01 UTC

News

NIO shares rose during after-market hours to about $4.50, as options sentiment showed mixed signals ahead of the upcoming earnings report.

14 sie 2026, 23:01 UTC

News

Realty Income Corp closed a $1.0 billion private offering of convertible senior notes, with proceeds for share repurchases and debt repayment. Shares are higher in after-market trading.

Peer Comparison

Price change

Bausch Health Cos Inc Forecast

Price Target

By TipRanks

22.89% upside

12 Months Forecast

Average 8 USD  22.89%

High 9 USD

Low 7 USD

Based on 2 Wall Street analysts offering 12 month price targets forBausch Health Cos Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

2 ratings

0

Buy

2

Hold

0

Sell

Sentiment

By Acuity

43 / 340 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Bausch Health Cos Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
help-icon Live chat